Manomay Tex India manufactures and sells denim fabrics and cotton yarn, recently expanding into the direct-to-consumer market with its own brand of denim apparel sold via e-commerce.
The company operates in a highly commoditized textile industry with low net margins (1.4%) and ROCE (10%) that do not suggest a durable competitive advantage. While they claim a 'partner of choice' status, the lack of pricing power and high debt levels indicate they are price-takers in a fragmented market.
Management has aggressively pursued vertical integration, moving from weaving into spinning (2024) and retail (2025). This has been funded by significant debt, resulting in a high D/E ratio of 2.04 and thin interest coverage of 1.84, suggesting a high-risk approach to growth.
The aggressive pivot into capital-intensive spinning and retail, funded by excessive leverage, proved fatal when a cyclical downturn in the textile market compressed already razor-thin margins. With a debt-to-equity ratio over 2.0 and interest coverage barely above 1.8, the company lacked the financial cushion to withstand rising interest rates and inventory gluts. The resulting liquidity crunch forced dilutive capital raises and asset fire sales, as the business was unable to service its debt from its meager 1.4% net margins, ultimately destroying shareholder value through financial distress.
RichFakir rates Manomay Tex India Ltd's business quality as poor — 35/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Manomay Tex India Ltd is trading about 57% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Manomay Tex India Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Manomay Tex India Ltd's fair value is about ₹154 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →